Understanding Autoimmune Hypoparathyroidism
At a Glance
Autoimmune hypoparathyroidism occurs when the immune system attacks the parathyroid glands, sometimes as part of APS-1 caused by AIRE gene changes. Care focuses on individualized calcium and vitamin D management, kidney protection, and lifelong monitoring for other autoimmune conditions.
If you have been diagnosed with autoimmune hypoparathyroidism, you have likely navigated a difficult path to get here. Because this is a rare disease—affecting a small fraction of the population—many patients experience significant delays in diagnosis, often spending years being told their symptoms are due to stress, anxiety, or more common conditions [1][2].
Receiving this diagnosis can feel overwhelming, but it is also a vital turning point. It provides a biological explanation for the intense physical and emotional symptoms you may have been feeling, from muscle cramps and tingling to fatigue [3]. (Note that cognitive symptoms like “brain fog” are common but nonspecific and can persist despite normal calcium, or be caused by other overlapping issues.) Understanding the nature of this condition is the first step toward regaining control.
A Rare Path Among the Uncommon
Hypoparathyroidism itself is uncommon, but the autoimmune form is especially rare. Most cases of hypoparathyroidism (estimated between 67% and 88% in various registries) are post-surgical, meaning the parathyroid glands were accidentally damaged or removed during neck surgery [4][5].
When you have the autoimmune form, your body’s own immune system mistakenly attacks the parathyroid glands, which are responsible for regulating calcium levels [6]. Because most general endocrinologists primarily see post-surgical patients, seeking care from an experienced clinician at a rare endocrine center is often recommended [4]. You may face risks of certain complications, such as seizures or kidney issues, if the condition is not well-controlled, making specialized care and close monitoring essential [7][8].
Two Forms of Autoimmune Hypoparathyroidism
Doctors distinguish between two main ways this condition appears:
- Isolated Autoimmune Hypoparathyroidism: This occurs when the parathyroid glands are the only target of the immune attack [9]. The causes of isolated cases are heterogeneous, and many patients have no proven genetic mutation.
- Autoimmune Polyendocrine Syndrome Type 1 (APS-1/APECED): This is a more complex syndrome where the immune system attacks multiple organs. It is classically defined by a “triad” of symptoms: hypoparathyroidism, chronic mucocutaneous candidiasis (persistent, severe yeast infections of the skin, nails, or mouth, distinct from ordinary common yeast infections), and adrenal insufficiency (Addison’s disease) [10][11].
Even if your hypoparathyroidism currently appears to be “isolated,” some patients later develop other parts of the APS-1 syndrome, though this is not true for everyone [12].
Understanding the Mechanism: The Role of AIRE
In cases of APS-1, the condition is caused by a failure in the body’s “education system” for immune cells, governed by a protein called AIRE (Autoimmune Regulator) [13].
- The “Schoolhouse” for T-Cells: Your thymus (a small gland in the chest) acts like a schoolhouse where immune cells called T-cells learn to distinguish between “self” and “foreign” invaders [13].
- The Failure of Tolerance: In people with loss-of-function mutations in the AIRE gene, T-cells are not properly educated. Autoreactive T-cells graduate into the body, where they attack the parathyroid glands as if they were a threat [13][14].
It is important to note that a negative AIRE test does not disprove autoimmunity. Many isolated cases do not evolve into APS-1, but because of the potential for autoimmune overlap, long-term monitoring for other conditions—such as thyroid disease, vitiligo, or type 1 diabetes—is a standard part of care [15][16]. Managing this condition requires more than just taking calcium. It involves a lifelong, individualized approach to balance calcium and vitamin D while protecting your kidneys [17][18].
Urgent Adrenal Warning: If you have or suspect you have APS-1, you must be aware of the signs of an adrenal crisis. This is a life-threatening emergency caused by low cortisol. Seek immediate emergency care if you experience severe weakness, vomiting, diarrhea, intense abdominal pain, dehydration, fainting, confusion, or severe low blood pressure.
Common questions in this guide
How does the immune system cause hypoparathyroidism?
Does having autoimmune hypoparathyroidism mean I have APS-1?
Can a negative AIRE gene test rule out autoimmune hypoparathyroidism?
What symptoms may occur with autoimmune hypoparathyroidism?
What other autoimmune conditions should be checked for?
Why might specialist care help with this rare condition?
Which symptoms of adrenal crisis require emergency help?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Specialist care
Should I seek care from an experienced clinician at a rare endocrine center?
Related health checks
Should I be monitored for thyroid disease, vitiligo, or type 1 diabetes over time?
Long-term management
Should my calcium and vitamin D be adjusted over time to protect my kidneys?
Get notified when new evidence is published on Autoimmune hypoparathyroidism.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (18)
- 1
Autoimmune polyendocrine syndrome type 1 (APECED) in the Indian population: case report and review of a series of 45 patients.
Fierabracci A, Arena A, Toto F, et al.
Journal of endocrinological investigation 2021; (44(4)):661-677 doi:10.1007/s40618-020-01376-5.
PMID: 32767280 - 2
The multiple faces of autoimmune Addison's disease in children.
Capalbo D, Esposito A, Gaeta V, et al.
Frontiers in endocrinology 2024; (15()):1411774 doi:10.3389/fendo.2024.1411774.
PMID: 39351530 - 3
Hypoparathyroidism: translating science from the laboratory to the clinic.
Brandi ML, AbuAlrob H, Chang W, et al.
The lancet. Diabetes & endocrinology 2026; (14(11)):927-951 doi:10.1016/S2213-8587(26)00188-9.
PMID: 42705258 - 4
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy.
Marcucci G, Cianferotti L, Parri S, et al.
Calcified tissue international 2018; (103(2)):151-163 doi:10.1007/s00223-018-0411-7.
PMID: 29511787 - 5
The Russian Registry of Chronic Hypoparathyroidism.
Kovaleva EV, Eremkina AK, Elfimova AR, et al.
Frontiers in endocrinology 2022; (13()):800119 doi:10.3389/fendo.2022.800119.
PMID: 35250859 - 6
Immunosuppressive therapy of autoimmune hypoparathyroidism in a patient with activating autoantibodies against the calcium-sensing receptor.
Chamberlin M, Kemp EH, Weetman AP, et al.
Clinical endocrinology 2019; (90(1)):214-221 doi:10.1111/cen.13886.
PMID: 30358904 - 7
Identifying Clinical Characteristics of Hypoparathyroidism in Turkey: HIPOPARATURK-NET Study.
Konca Degertekin C, Gogas Yavuz D, Pekkolay Z, et al.
Calcified tissue international 2022; (110(2)):204-214 doi:10.1007/s00223-021-00908-2.
PMID: 34495356 - 8
Hipopara-Red, Real Life Experience in 322 Patients With Hypoparathyroidism.
Zanchetta MB, Robbiani D, Oliveri B, et al.
Journal of the Endocrine Society 2021; (5(2)):bvaa181 doi:10.1210/jendso/bvaa181.
PMID: 33409439 - 9
Multiplex Autoantibody Detection in Patients with Autoimmune Polyglandular Syndromes.
Savvateeva EN, Yukina MY, Nuralieva NF, et al.
International journal of molecular sciences 2021; (22(11)) doi:10.3390/ijms22115502.
PMID: 34071130 - 10
Rapid whole-genome sequencing identifies a novel AIRE variant associated with autoimmune polyendocrine syndrome type 1.
Sanford E, Watkins K, Nahas S, et al.
Cold Spring Harbor molecular case studies 2018; (4(3)) doi:10.1101/mcs.a002485.
PMID: 29437776 - 11
Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: report of three cases from Iran.
Seifi-Alan M, Shamsi R, Setoodeh A, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2016; (29(8)):979-83.
PMID: 27105486 - 12
Spectrum of germline AIRE mutations causing APS-1 and familial hypoparathyroidism.
Cranston T, Boon H, Olesen MK, et al.
European journal of endocrinology 2022; (187(1)):111-122 doi:10.1530/EJE-21-0730.
PMID: 35521792 - 13
FBXO3 Protein Promotes Ubiquitylation and Transcriptional Activity of AIRE (Autoimmune Regulator).
Shao W, Zumer K, Fujinaga K, Peterlin BM
The Journal of biological chemistry 2016; (291(34)):17953-63 doi:10.1074/jbc.M116.724401.
PMID: 27365398 - 14
Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1.
Landegren N, Sharon D, Freyhult E, et al.
Scientific reports 2016; (6()):20104 doi:10.1038/srep20104.
PMID: 26830021 - 15
New Approach to Addison Disease: Oral Manifestations Due to Endocrine Dysfunction and Comorbidity Burden.
Bugălă NM, Carsote M, Stoica LE, et al.
Diagnostics (Basel, Switzerland) 2022; (12(9)) doi:10.3390/diagnostics12092080.
PMID: 36140482 - 16
A novel compound heterozygous mutation of the AIRE gene in a patient with autoimmune polyendocrine syndrome type 1.
Suh J, Choi HS, Kwon A, et al.
Annals of pediatric endocrinology & metabolism 2019; (24(4)):248-252 doi:10.6065/apem.2019.24.4.248.
PMID: 31905445 - 17
[Review of clinical practice guidelines for hypoparathyroidism].
Kovaleva EV, Eremkina AK, Krupinova JA, et al.
Problemy endokrinologii 2021; (67(4)):68-83 doi:10.14341/probl12800.
PMID: 34533015 - 18
Epidemiology and Diagnosis of Hypoparathyroidism.
Clarke BL, Brown EM, Collins MT, et al.
The Journal of clinical endocrinology and metabolism 2016; (101(6)):2284-99 doi:10.1210/jc.2015-3908.
PMID: 26943720
This page is for informational purposes only and does not constitute medical advice or diagnose autoimmune hypoparathyroidism. Your endocrinologist should interpret your test results and create a personalized plan for calcium, vitamin D, kidney, and adrenal monitoring.